Fundraising FoxFrazier — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
A pharmaceutical company that markets a portfolio of drug products across various dosage forms, with labeling and packaging following FDA requirements.
Advanced ManufacturingBiotechHealthtechLogistics & Supply Chain
Rick Ryan(Executive Director and Founder, WSI)Benjamin Hall(Chief Executive Officer)inDavid Arnold(President/Chief Operating Officer)inSonia De La Rosa(Chief Commercial Officer, Corporate Development and Strategy)in
Co-investorsFrazier Healthcare PartnersFulcrum Equity PartnersNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.